Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2Venous Thromboembolism 2Neoplasms 2Pulmonary Embolism 1Hemorrhage 1

Interventions

Dalteparin 9apixaban 6Heparin, Low-Molecular-Weight 3Enoxaparin 3edoxaban 2abelacimab 2Tinzaparin 2Rivaroxaban 2MAA868 2Dabigatran 2isoquercitrin 1enoxaparin sodium 1bemiparin 1Warfarin 1Rosuvastatin Calcium 1Fondaparinux 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Embolism × bemiparin × Classical hematology × Clear all
NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡